DUBLIN--(BUSINESS WIRE)--The "North America's Electrophysiology Market 2019-2024: Growth, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
The North American electrophysiology market is expected to register a CAGR of nearly 6.7% during the forecast period, 2019-2024.
- North America is expected to increase its share in the electrophysiology market in the future, owing to the presence of well-established healthcare facilities and rise in the number of arrhythmia and heart failure cases in the region.
- Electrophysiology devices have major applications in detecting heart failure rates, and the increasing number of heart failures is expected to drive the market over the forecast period.
- According to the American Heart Association Research Report 2017, about 92.1 million American adults are suffering from some form of cardiovascular disease or the after-effects of stroke.
- The other factors, such as high adoption rates in the emerging markets in the North American region, due to technological advancements, rapid growth in aging population, an increase in demand for catheter ablation procedures are also driving the market.
- However, due to lack of mobility among the majority of established electrophysiologists, there is a distinct lag in their geographical dispersion, resulting in a rift between the demand and supply and a visible disparity among electrophysiologists.
- The lack of skilled electrophysiologists is acting as a major restraint in the North American electrophysiology market. Additionally, unfavorable healthcare reforms are also responsible for hindering the growth of the market.
Ablation Catheters Segment Anticipated to Hold Significant Share in the Market
Ablation catheters are useful in removing anomalous heart tissues that may result in irregular heartbeats. These devices work on the basis of ablation, which is a minimally invasive procedure that employs catheters to demolish the defective electrical pathways from the heart. Radiofrequency ablation and cryoablation are the most commonly used types of ablation catheters, and both are expected to hold significant market shares, aided by related advancements in the technology.
Radiofrequency (RF) ablation uses locally delivered high-energy RF signals to make the scars. On the other hand, cryoablation uses extremely cold temperatures for making the scars. Laser light energy is also used for the same. In January 2017, Abbott launched its new EnSite Precision Cardiac Mapping System and Advisor FL Circular Mapping Catheter-Sensor Enabled to map cardiac arrhythmias during ablation treatments.
The North American electrophysiology market, which is highly competitive, consists of a few major players, who currently dominate the market, in terms of market shares. Companies, such as Abbott Laboratories, Boston Scientific Corporation, and Medtronic, among others, hold substantial shares in the North American electrophysiology market.
Recently, various developments have been taking place in the market. For instance, in January 2018, BioSig Technologies, a medical device company engaged in the development of a biomedical signal processing platform, designed to address the demand for electrophysiology market, partnered with Mr. Charles Austin and JK Advisors to scale up the operational activities.
In January 2018, Rhythmlink announced the patent license agreement with Dignity Health for improving and expanding brain health monitoring options. The proprietary technology by Dignity Health allows quick and easy collection of EEG data, which can be further distributed to healthcare personnel for analysis and intervention.
Key Topics Covered
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Target Diseases
4.2.2 Technological Advancements in the Field of Electrophysiology
4.2.3 Increasing Demand for Catheter Ablation Procedures
4.3 Market Restraints
4.3.1 Lack of Skilled And Experienced Electrophysiologists
4.3.2 Unfavorable Healthcare Reforms
4.4 Porter's Five Forces Analysis
5 MARKET SEGMENTATION
5.1.1 Ablation Catheters
188.8.131.52 Cryoablation EP Catheters
184.108.40.206 Radiofrequency Ablation Catheters
220.127.116.11 Microwave Ablation Systems
18.104.22.168 Laser Ablation Systems
22.214.171.124 Other Ablation Catheters
5.1.2 Laboratory Devices
126.96.36.199 EP X-Ray Systems
188.8.131.52 3D Mapping Systems
184.108.40.206 EP Recording Systems
220.127.116.11 EP Remote Steering Systems
18.104.22.168 Other Laboratory Devices
5.1.3 Diagnostic Catheters
22.214.171.124 Conventional EP Diagnostic Catheters
126.96.36.199 Advanced EP Diagnostic Catheters
188.8.131.52 Ultrasound EP Diagnostic Catheters
5.1.4 Access Devices
5.1.5 Other Products
5.2 Target Disease
5.2.1 Atrial Fibrillation
5.2.2 Atrial Flutter
5.2.3 Wolff-Parkinson-White Syndrome
5.2.4 Atrioventricular Nodal Re-entry Tachycardia
5.2.5 Other Target Diseases
5.3.1 North America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Biotronik SE & Co. KG
6.1.3 Boston Scientific
6.1.4 GE Healthcare
6.1.5 Hansen Medical
6.1.6 Johnson & Johnson
6.1.7 Medtronic Inc.
6.1.8 Nihon Kohden Corporation
6.1.9 Siemens Healthcare
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/v9g2bv